| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/12/2004 | WO2004012740A1 MEDICINAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR |
| 02/12/2004 | WO2004012735A2 New effector conjugates, process for their production and their pharmaceutical use |
| 02/12/2004 | WO2004012734A1 Patch for transdermal administration |
| 02/12/2004 | WO2004012730A1 Improved transdermal delivery system for the administration of rotigotine |
| 02/12/2004 | WO2004012722A2 Bicifadine formulation |
| 02/12/2004 | WO2004012719A1 Improved transdermal delivery system |
| 02/12/2004 | WO2004012718A1 New film coating |
| 02/12/2004 | WO2004012715A1 Sustained release formulations of metformin |
| 02/12/2004 | WO2004012713A1 Delayed release anti-viral product, use and formulation thereof |
| 02/12/2004 | WO2004012712A1 Methods and compositions for treating benign gynecological disorders, contraception, and hormone replacement |
| 02/12/2004 | WO2004012710A1 Crystalline drug particles prepared using a controlled precipitation (recrystallization) process |
| 02/12/2004 | WO2004012708A1 Intravenous pharmaceutical form of administration |
| 02/12/2004 | WO2004012703A1 Injectable depot compositions and uses thereof |
| 02/12/2004 | WO2004012702A1 New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
| 02/12/2004 | WO2004012680A2 Lipid-drug complexes in reversed liquid and liquid crystalline phases |
| 02/12/2004 | WO2004012662A2 Improved treatment of cancer with glutamine |
| 02/12/2004 | WO2004012653A2 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 02/12/2004 | WO2004012651A2 Composition for heart disease, method to prepare same and uses thereof |
| 02/12/2004 | WO2003103596A3 Stabilized nanoparticle formulations of camptotheca derivatives |
| 02/12/2004 | WO2003097106A3 Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent |
| 02/12/2004 | WO2003094963A3 Methylated immunostimulatory oligonucleotides and methods of using the same |
| 02/12/2004 | WO2003093462A3 Immobilisation and stabilisation of virus |
| 02/12/2004 | WO2003087824A3 Charge-balanced chemoselective linkers |
| 02/12/2004 | WO2003086305A8 Biodegradable peg-based polymer formulations in ocular applications |
| 02/12/2004 | WO2003082329A3 Compositions and compounds for use as molecular adjuvant for a nicotine vaccine |
| 02/12/2004 | WO2003079885A3 Inhalable sustained therapeutic formulations |
| 02/12/2004 | WO2003077882A3 Preparation of sterile stabilized nanodispersions |
| 02/12/2004 | WO2003070968A3 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/12/2004 | WO2003064496A3 Biodegradable polymer |
| 02/12/2004 | WO2003060142A3 Compositions and methods for controlled release |
| 02/12/2004 | WO2003057136A3 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it |
| 02/12/2004 | WO2003053325A8 Microencapsulation of drugs by solvent exchange |
| 02/12/2004 | WO2003050502A3 Prospective identification and characterization of breast cancer stem cells |
| 02/12/2004 | WO2003039485A3 Stable liquid pharmaceutical formulation of igg antibodies |
| 02/12/2004 | WO2003039331A3 Method for improving stability of a bone-connecting implant |
| 02/12/2004 | WO2003035012A3 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 02/12/2004 | WO2003033670A3 Method for preparation of single chain antibodies |
| 02/12/2004 | WO2003033653B1 Affinity enhancement agents |
| 02/12/2004 | WO2002100344A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 02/12/2004 | WO2002100338A3 Compound and composition for delivering active agents |
| 02/12/2004 | WO2002081507A3 Interferon gamma polypeptide variants |
| 02/12/2004 | US20040030380 Drug-delivery endovascular stent and method for treating restenosis |
| 02/12/2004 | US20040030188 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same |
| 02/12/2004 | US20040030151 Stable amorphous celecoxib composite and process therefor |
| 02/12/2004 | US20040030101 Interferon conjugates |
| 02/12/2004 | US20040030033 New film coating |
| 02/12/2004 | US20040029977 Fine-grained emulsions |
| 02/12/2004 | US20040029970 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss |
| 02/12/2004 | US20040029967 Phenylethylamine derivatives and their use in the treatment of melanoma |
| 02/12/2004 | US20040029964 Calcium formate for use as a dietary supplement |
| 02/12/2004 | US20040029959 Isosorbide mononitrate compositions and methods of their use |
| 02/12/2004 | US20040029946 Topical applying |
| 02/12/2004 | US20040029934 Pharmaceutical emulsion preparation |
| 02/12/2004 | US20040029927 Oral administering of tablet of triprolidine |
| 02/12/2004 | US20040029924 Administering by mouth; enteric cellulose coated pellets; gastrointestinal disorders |
| 02/12/2004 | US20040029907 Drug for respiratory system disorders |
| 02/12/2004 | US20040029892 Compositions and dosage forms for application in the oral cavity in the treatment of mykoses |
| 02/12/2004 | US20040029890 PH sensitivity; controlling blood concentration; cardiovascular disorders |
| 02/12/2004 | US20040029869 Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine |
| 02/12/2004 | US20040029856 Photodynamic therapy for the treatment of hair loss |
| 02/12/2004 | US20040029855 Composition |
| 02/12/2004 | US20040029854 Nirtic oxide donors based on metallic centres |
| 02/12/2004 | US20040029851 Therapy for oxidation stresses; complex of drug and enzyme mimetics |
| 02/12/2004 | US20040029831 Extracts of kava-kava |
| 02/12/2004 | US20040029821 Pharmaceutical composition containing an indolopyrrolocarbazole derivative |
| 02/12/2004 | US20040029807 For therapy of hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock |
| 02/12/2004 | US20040029794 Immobilizated growth hormone releasing factor |
| 02/12/2004 | US20040029784 Administering glucagon-like peptide; reducing insulin resistance |
| 02/12/2004 | US20040029782 Antiinflammatory agents; osteoporosis; cardiovascular disorders; coating for prosthetics |
| 02/12/2004 | US20040029778 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery |
| 02/12/2004 | US20040029777 Pharmaceutical preparation for taste masking |
| 02/12/2004 | US20040029776 Hydroxyethyl starch - containing polypeptide compositions |
| 02/12/2004 | US20040029771 Methods for treating diseases related to intraocular pressure |
| 02/12/2004 | US20040029761 O/W emulsion composition and method of preparing the same |
| 02/12/2004 | US20040029281 Carrier vectors through an epithelium with tight junctions |
| 02/12/2004 | US20040029250 Method and device for sanitation using bacteriophages |
| 02/12/2004 | US20040029244 Phospholipase d effectors for therapy and screening |
| 02/12/2004 | US20040029182 For diagnosis/therapy of colorectal cancer |
| 02/12/2004 | US20040029179 Higher molecular weight entities and uses therefor |
| 02/12/2004 | US20040028752 Hemorrhoids therapy |
| 02/12/2004 | US20040028746 Crystalline drug particles prepared using a controlled precipitation (recrystallization) process |
| 02/12/2004 | US20040028745 Mixture for sustained release; crosslinked alginate; anticancer agents |
| 02/12/2004 | US20040028744 Topical applying; bioadhesive for mucous membrane; low temperature storage stability |
| 02/12/2004 | US20040028743 Brandycardial agents |
| 02/12/2004 | US20040028740 Transferring to cells; gene therapy; active drug in lipophilic matrix |
| 02/12/2004 | US20040028739 Wound gels |
| 02/12/2004 | US20040028736 Macromolecules; oral administering; mixture of active material and aromatic alcohol |
| 02/12/2004 | US20040028733 Therapy for fertility disorders; stabilized follicle stimulating hormone |
| 02/12/2004 | US20040028732 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 02/12/2004 | US20040028725 Transdermal delivery of hormones |
| 02/12/2004 | US20040028724 Pharmaceutical preparation of percutaneous absorption type |
| 02/12/2004 | US20040028723 Matrix with permeable reservoir containing ergoline compound; diffusion barrier |
| 02/12/2004 | US20040028722 Microbial cellulose wound dressing for treating chronic wounds |
| 02/12/2004 | US20040028704 Administering botulinum toxin |
| 02/12/2004 | US20040028703 Genetic engineered, low molecular weight drug; therapy, vaccine; extraction of Clostridium |
| 02/12/2004 | US20040028698 Vaccine |
| 02/12/2004 | US20040028694 Novel nanoparticles and use thereof |
| 02/12/2004 | US20040028687 Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues |
| 02/12/2004 | US20040028686 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplated organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 02/12/2004 | US20040028654 Protamine-adenoviral vector complexes and methods of use |